Dr. Dixit Thakur

Dr. Dixit Kumar Thakur Explains Why Delhi’s Air Is Worsening Asthma — And What Is the Best Asthma Treatment in Delhi Right Now

By Dr. Dixit Kumar Thakur 

“In my 13+ years at Pulmovista, I’ve seen asthma surge every October. The pollution isn’t just irritating airways anymore — it is fundamentally changing the biology of the disease. And in 2026, we are finally treating it that way.” — Dr. Dixit Kumar Thakur

If your asthma has become harder to control in 2026, you are not alone — and you are not imagining it. As Delhi’s best asthma specialist, Dr. Dixit Kumar Thakur has been treating respiratory patients in this city for over 13 years, and the pattern is unmistakable: every year, as October approaches, the clinic fills with patients whose previously well-managed asthma has suddenly deteriorated. The culprit is no mystery. It is Delhi’s air.

But this is not a story of helplessness. Driven by the PM2.5 crisis and aligned with GINA 2026 precision treatment guidelines, Pulmovista Clinics now offers Delhi’s most advanced, personalised asthma care — from cutting-edge diagnostics to biologic therapies that are changing lives. In this article, Dr. Dixit Kumar Thakur walks you through exactly what is happening to your lungs, why standard treatment is often not enough, and what the best asthma treatment in Delhi looks like in 2026.

1. The PM2.5 Crisis: Why Delhi Is One of the Worst Cities in the World for Asthma

When Dr. Dixit Kumar Thakur talks to asthma patients at Pulmovista Clinics about why their symptoms have worsened, the conversation almost always starts with one number: PM2.5.

What Is PM2.5 and Why Should Every Asthma Patient in Delhi Fear It?

PM2.5 refers to airborne particulate matter smaller than 2.5 micrometres in diameter — roughly one-thirtieth the width of a human hair. These particles are so fine that they bypass every natural defence your body has: your nose hairs, your mucus membranes, and even your upper bronchial tubes. They travel straight into the deepest parts of your lungs — and stay there.

For asthma patients, PM2.5 does far more than irritate. Dr. Dixit Kumar Thakur explains the biological cascade that PM2.5 sets off in sensitised airways:

Airway hyper-responsiveness: PM2.5 primes your airways to overreact to even minor triggers — a cold gust of air, a mild perfume, or light exercise can cause bronchospasm that would not have affected you in cleaner air.

Oxidative stress: Fine particles generate free radicals that damage the bronchial epithelium (airway lining), triggering sustained inflammation long after the pollution exposure has passed.

Neutrophilic inflammation: Unlike typical allergic asthma, PM2.5-driven inflammation is predominantly neutrophilic — a type that responds poorly to standard inhaled corticosteroids, making your usual preventer inhaler less effective.

Mucus hypersecretion: Chronic PM2.5 exposure stimulates goblet cells to overproduce mucus, narrowing airways and worsening nighttime cough and breathlessness.

Reduced drug delivery: Inflamed, mucus-filled airways absorb inhaled medication poorly — meaning patients need higher doses or different drug delivery strategies to achieve the same effect.

PollutantDelhi 2026 Level vs. Safe Limit
PM2.5 (Fine Particulate)~85–110 µg/m³ annual avg. | WHO limit: 15 µg/m³ (5–7× over limit)
PM10 (Coarse Particulate)~180–220 µg/m³ | WHO limit: 45 µg/m³
NO₂ (Vehicle Exhaust)~60–80 µg/m³ | Triggers airway inflammation
Ground-Level OzonePeaks in summer afternoons | Potent bronchospasm trigger
SO₂ (Industrial)From NCR factories & power plants | Aggravates reactive airways
⚠  What Dr. Dixit Kumar Thakur Wants Every Delhi Resident to Know About PM2.5 ›  Delhi’s annual PM2.5 average is 5–7 times the WHO safe limit — every single year. ›  A single day of hazardous AQI exposure can destabilise asthma for several days afterward. ›  Children inhale more pollutants per kg of body weight than adults — making paediatric asthma a growing public health crisis in Delhi. ›  Even patients who feel ‘okay’ on high-pollution days may have measurable, silent loss of lung function.

Why Delhi’s PM2.5 Problem Is Getting Worse in 2026

Dr. Dixit Kumar Thakur identifies five structural drivers that continue to worsen Delhi’s air quality crisis:

Explosive vehicle growth: Delhi’s registered vehicle count now exceeds 13 million. Diesel engines remain the single largest source of PM2.5 and NO₂ in the city.

Uncontrolled construction dust: Rapid infrastructure expansion — metro extensions, highways, and residential towers — generates silica-laden dust year-round.

Seasonal stubble burning: Every October–November, mass crop residue burning in Punjab and Haryana sends a dense pollution plume directly into Delhi, routinely pushing the AQI beyond 400–500 (Hazardous).

Winter temperature inversions: Cold, dense air near the surface traps all local pollution below a warmer atmospheric layer. PM2.5 concentrations can triple during inversion events, with no wind to provide relief.

Industrial emissions from NCR: Factories and thermal power plants in the National Capital Region continuously discharge sulphur dioxide and volatile organic compounds that react with sunlight to form secondary PM2.5.

2. Seasonal Asthma Triggers in Delhi: Dr. Dixit Kumar Thakur’s Month-by-Month Warning Guide

One of the most valuable things Dr. Dixit Kumar Thakur does at Pulmovista Clinics is help patients anticipate their worst periods before they arrive — rather than scrambling after a crisis. Understanding Delhi’s seasonal trigger calendar is essential for any asthma patient in this city.

🌫️ October – February: The Danger Season (Act Now, Not After)

Every October, Dr. Dixit Kumar Thakur sees a sharp rise in emergency consultations and exacerbation reviews at Pulmovista Clinics. October is the month everything converges:

Stubble burning smoke (October–November): The single most dramatic acute pollution event of the year for asthma patients in Delhi. PM2.5 spikes from stubble burning are severe enough to cause attacks in patients who have been asymptomatic for months.

Diwali firecrackers: In the days around Diwali, Delhi’s AQI routinely exceeds 999 — the maximum measurable value. Sulphur compounds, heavy metals, and ultrafine particles from firecrackers are acutely toxic to inflamed airways.

Temperature inversions (November–February): Cold winter air traps pollution at ground level for days or weeks. Morning PM2.5 values in January and February frequently exceed 200–300 µg/m³ — twenty times the WHO daily guideline.

Cold, dry air: A direct bronchospasm trigger. Breathing air below 10°C causes rapid airway constriction, particularly during the pre-dawn hours when temperatures are lowest and many patients wake with wheezing.

Indoor mould: Sealed, poorly ventilated winter homes create ideal mould growth conditions. Aspergillus and Cladosporium spores are potent allergens for atopic asthmatics.

“My message to every asthma patient in Delhi is this: October is your preparation month, not your reaction month. Come to Pulmovista in September. Get your spirometry done. Review your action plan. Do not wait for your first severe attack to seek care.” — Dr. Dixit Kumar Thakur, Pulmovista Clinics — Best Asthma Treatment in Delhi

🌸 March – May: Pollen Season — Allergic Asthma at Its Peak

Spring in Delhi is beautiful but brutal for patients with allergic asthma — the most common asthma phenotype that Dr. Dixit Kumar Thakur treats at Pulmovista Clinics.

Mulberry (Morus alba) pollen: One of the most allergenic tree pollens in North India, peaking in March–April. Patients sensitised to mulberry pollen experience dramatic symptom spikes during this window.

Grass pollens (April–May): As temperatures rise, grass pollen counts escalate and remain high through May, overlapping with ozone season.

Afternoon ozone peaks: Photochemical reactions between vehicle NOx and sunlight produce ground-level ozone, peaking between 2–4 PM. Ozone is a direct airway irritant that causes chest tightness, coughing, and airflow reduction.

Pre-monsoon dust storms: ‘Andhis’ carry enormous quantities of coarse and fine dust that trigger immediate airway inflammation in sensitised patients.

🌧️ June – September: Monsoon Mould Explosion

The monsoon reduces dust and pollen but introduces a new, underappreciated trigger: mould. At Pulmovista Clinics, Dr. Dixit Kumar Thakur regularly sees patients whose asthma deteriorates in July and August without obvious cause — mould sensitisation is almost always the explanation.

Alternaria and Aspergillus moulds: Warm, humid monsoon conditions cause an exponential increase in outdoor and indoor mould spore counts. Both genera are strongly linked to severe asthma exacerbations and are commonly under-diagnosed.

Thunderstorm asthma: A well-documented phenomenon where pre-monsoon thunderstorm downdrafts rupture pollen grains, releasing sub-pollen particles that penetrate deep into the bronchioles — causing sudden, severe asthma attacks in previously mild patients.

Cockroach allergen surge: Monsoon humidity drives cockroach population explosions in Delhi homes. Cockroach droppings are a year-round allergen but reach peak concentrations during and after the monsoon.

3. Why Standard Asthma Treatment Is Failing Delhi Patients — A Frank Assessment by Dr. Dixit Kumar Thakur

As a pulmonologist in Delhi who sees patients referred from across the NCR, Dr. Dixit Kumar Thakur regularly encounters patients who have been on the same two inhalers for years — a blue rescue inhaler and a brown preventer — without ever having a proper assessment of whether their treatment is actually working. The result is a city full of patients who are ‘managing’ asthma rather than controlling it.

Signs Your Current Asthma Treatment in Delhi Is Not Working ✔  You use your rescue (blue) inhaler more than 2 times per week for symptom relief ✔  You wake up at night coughing, wheezing, or with chest tightness ✔  Your asthma limits your walking, climbing stairs, exercise, or work ✔  You have needed oral steroids (prednisolone) or a hospital visit in the past 12 months ✔  You feel your symptoms are ‘season-dependent’ and accept this as normal ✔  You have never had spirometry, FeNO, or allergy testing done

Dr. Dixit Kumar Thakur identifies the most common reasons why asthma treatment fails in Delhi:

Pollution-driven asthma is partially steroid-resistant: PM2.5-induced neutrophilic inflammation responds poorly to inhaled corticosteroids (ICS) — the cornerstone of standard asthma therapy. Patients taking ICS faithfully may still have significant uncontrolled inflammation because the pollution phenotype is not steroid-sensitive.

Wrong inhaler device for the patient’s breathing pattern: Dry powder inhalers (DPIs) require a fast, forceful inhalation that many children and elderly patients cannot generate. Metered dose inhalers (MDIs) without spacers deliver less than 20% of drug to the lungs. Dr. Dixit Kumar Thakur assesses and corrects inhaler technique at every Pulmovista consultation.

Untreated allergic rhinitis sabotaging asthma control: The nose and the lung are one united airway. Chronic nasal inflammation from rhinitis drives post-nasal drip, nocturnal coughing, and airway sensitisation — making asthma perpetually harder to control. Over 60% of asthma patients at Pulmovista Clinics have concurrent allergic rhinitis that has never been adequately treated.

GERD (acid reflux) as a hidden asthma trigger: Gastro-oesophageal reflux causes micro-aspiration of acid into the airways — triggering nighttime asthma and chronic cough. Dr. Dixit Kumar Thakur screens all difficult-to-control asthma patients for GERD.

No objective monitoring — managing by feel alone: Without regular spirometry and FeNO measurements, silent loss of asthma control goes undetected. Many patients feel ‘okay’ while their FEV₁ is 30% below normal.

4. GINA 2026 Precision Treatment: The New Standard for Best Asthma Treatment in Delhi

The Global Initiative for Asthma (GINA) 2026 guidelines represent the most significant shift in asthma management philosophy in two decades. At Pulmovista Clinics, Dr. Dixit Kumar Thakur has fully integrated GINA 2026 precision treatment principles into every patient pathway — making it the foundation of the best asthma treatment in Delhi.

What GINA 2026 Precision Treatment Means in Practice

GINA 2026 moves away from the old ‘one-size-fits-all’ inhaler ladder and toward phenotype-guided, biomarker-driven therapy. This means:

Old ApproachGINA 2026 Precision ApproachImpact at Pulmovista Clinics
Treat symptomsTreat the underlying phenotypeCorrect therapy from consultation 1
Step-up by symptoms aloneStep-up guided by FeNO + eosinophils + spirometryObjective decisions, not guesswork
SABA (blue inhaler) as first rescueICS-formoterol as preferred rescue (MART strategy)Reduces exacerbations significantly
High-dose ICS long-termBiomarker-guided dose — minimum effective ICSReduces steroid side effects
Inhalers for all severe asthmaBiologic therapy for eligible severe asthmaLife-changing outcomes for right patients

Key GINA 2026 Changes That Dr. Dixit Kumar Thakur Has Implemented at Pulmovista

MART Strategy (Maintenance and Reliever Therapy): The same ICS-formoterol inhaler is used for both daily prevention AND as-needed rescue — replacing the traditional separate blue and brown inhalers. This has been shown to reduce severe exacerbations by up to 45% compared to SABA-based rescue therapy.

FeNO-guided ICS dosing: Fractional exhaled nitric oxide (FeNO) is measured at every follow-up visit. If FeNO is falling, ICS can be stepped down, reducing long-term steroid exposure. If FeNO is rising, the dose is adjusted before symptoms worsen.

Early biologic referral: GINA 2026 recommends earlier referral for biologic assessment — patients no longer need to ‘fail’ multiple treatments before accessing biologics.

Treatable traits approach: Every patient is assessed for multiple concurrent ‘treatable traits’ — eosinophilia, allergic rhinitis, GERD, obesity, anxiety — each of which contributes to asthma burden and can be specifically targeted.

5. Biologic Therapies for Asthma: Available at Pulmovista Clinics, Delhi

Biologic therapies represent the pinnacle of GINA 2026 precision treatment — and they are fully available at Pulmovista Clinics under Dr. Dixit Kumar Thakur’s expert guidance. These are injectable medicines that target the specific molecular pathways driving your asthma — going far beyond what any inhaler can achieve.

The Biologic Medicines Available for Asthma in Delhi

Biologic (Brand)How It WorksBest For
Omalizumab (Xolair)Blocks IgE antibodies — the master switch of allergic reactionsAllergic asthma + high total IgE
Mepolizumab (Nucala)Anti-IL-5: reduces eosinophil production in bone marrowSevere eosinophilic asthma
Benralizumab (Fasenra)Anti-IL-5Rα: directly depletes circulating eosinophilsFast-acting eosinophilic asthma
Dupilumab (Dupixent)Blocks IL-4 and IL-13 simultaneously — dual T2 pathwayAsthma + atopic dermatitis + nasal polyps
Tezepelumab (Tezspire)Blocks TSLP — the most upstream asthma trigger identifiedAll severe asthma phenotypes

What Outcomes Can Biologic Therapy Achieve?

When the right biologic is matched to the right patient — based on precise biomarker profiling as Dr. Dixit Kumar Thakur performs at Pulmovista Clinics — the results can be extraordinary:

• 50–75% reduction in severe asthma exacerbations per year

• Elimination or dramatic reduction of oral corticosteroid dependence

• Significant improvement in FEV₁ (lung function) within 3–6 months

• Marked improvement in quality of life, exercise capacity, and sleep

• Fewer emergency department visits and hospitalisations

• In some cases, reduction in daily inhaler requirements

✅  Pulmovista Biologic Therapy Assessment Pathway ✔  Step 1: Comprehensive history, examination, and asthma severity scoring by Dr. Dixit Kumar Thakur ✔  Step 2: Spirometry with bronchodilator reversibility testing ✔  Step 3: FeNO (exhaled nitric oxide) measurement ✔  Step 4: Blood eosinophil count + total IgE + specific allergen panel ✔  Step 5: Allergy skin prick testing when indicated ✔  Step 6: Biomarker review and biologic selection — personalised to your exact phenotype ✔  Step 7: Prescription, monitoring, and long-term follow-up at Pulmovista Clinics, Delhi

Who Qualifies for Biologic Therapy for Asthma in Delhi?

• Diagnosed with severe persistent asthma (GINA Step 4 or 5)

• Uncontrolled symptoms despite high-dose ICS-LABA combination therapy

• 2 or more severe exacerbations in the past 12 months (requiring oral steroids, ER visit, or hospitalisation)

• Elevated biomarkers: blood eosinophils ≥300 cells/µL, total IgE elevated, FeNO ≥25 ppb

• Significant quality of life impairment from daily asthma symptoms

6. Complete Asthma Diagnosis at Pulmovista Clinics: Why Testing Matters

At Pulmovista Clinics, Dr. Dixit Kumar Thakur does not diagnose asthma by symptoms alone. Many conditions mimic asthma — vocal cord dysfunction, cardiac asthma, COPD, and anxiety-related breathlessness among them. Equally, many asthma patients have comorbidities that are silently worsening their disease without being identified. Comprehensive testing is the foundation of the best asthma treatment in Delhi.

Diagnostic TestWhat It Tells Dr. Thakur
Spirometry + Bronchodilator TestConfirms airflow obstruction + reversibility = gold standard asthma diagnosis
FeNO (Exhaled Nitric Oxide)Quantifies eosinophilic airway inflammation; guides ICS dosing & biologic selection
Blood Eosinophil Count + IgEDetermines asthma phenotype; essential for biologic eligibility assessment
Allergy Skin Prick TestingIdentifies specific allergen triggers (dust mites, moulds, pollens, cockroach)
Peak Flow Variability (2–4 wks)Documents diurnal variability — a hallmark of asthma; useful when spirometry is normal
Methacholine Challenge TestConfirms airway hyper-responsiveness when spirometry is normal but symptoms persist
HRCT ChestRules out bronchiectasis, ABPA, interstitial lung disease, or structural abnormality
Sleep Study (Polysomnography)Detects obstructive sleep apnoea — a major hidden asthma co-driver

7. GINA 2026 Treatment Steps: How Dr. Dixit Kumar Thakur Treats Asthma at Pulmovista

GINA StepSeverityRecommended Treatment (GINA 2026)
Step 1Mild intermittentAs-needed low-dose ICS-formoterol (MART); avoid SABA-only
Step 2Mild persistentLow-dose daily ICS + as-needed ICS-formoterol OR LTRA add-on
Step 3Moderate persistentLow-dose ICS-LABA (MART strategy) + LTRA; review comorbidities
Step 4Severe persistentMedium-high ICS-LABA + LAMA (tiotropium) + LTRA; specialist review
Step 5Very severe / refractoryHigh-dose ICS-LABA + biologic therapy assessment at Pulmovista Clinics

Beyond Inhalers: Additional Treatments Available at Pulmovista Clinics

Allergen Immunotherapy (AIT): Subcutaneous injections or sublingual drops that desensitise patients to specific allergens over 3–5 years — the only treatment that can modify the underlying allergic disease, not just suppress symptoms.

Azithromycin (low-dose macrolide): Evidence-based add-on for non-eosinophilic (neutrophilic) asthma — the pollution-driven asthma phenotype particularly common in Delhi patients.

Bronchial Thermoplasty: A minimally invasive bronchoscopic procedure for carefully selected severe refractory asthma patients. Reduces airway smooth muscle mass to decrease bronchospasm frequency.

Pulmonary Rehabilitation: Structured exercise and breathing training programme for patients with significant exercise limitation — available at Pulmovista Clinics.

CPAP therapy: For patients with obstructive sleep apnoea comorbidity — treating OSA significantly improves asthma control in overlap patients.

8. Environmental Protection: Dr. Dixit Kumar Thakur’s Practical Guide for Asthma Patients in Delhi

The best asthma treatment in Delhi is not just about medicines — it is about controlling what enters your airways. Dr. Dixit Kumar Thakur provides every Pulmovista patient with personalised environmental counselling as part of their care plan.

Outdoor Precautions

Download the Safar-Air or AQI India app and check the daily AQI before stepping outside. Limit outdoor exposure when AQI exceeds 150 (Unhealthy).

Wear a properly fitted N95 or N99 respirator mask — not a cloth or surgical mask — whenever outdoors on moderate-to-high AQI days. The difference in PM2.5 filtration is dramatic.

Avoid exercising outdoors in the early morning (peak PM2.5 hours) and during afternoon ozone peaks (2–4 PM in summer).

During Diwali and October–November stubble burning season, treat outdoor exposure as a medical risk — minimise all unnecessary trips outside.

Indoor Air Quality: Your Lung’s Last Line of Defence

Invest in a true HEPA air purifier (CADR ≥150 m³/hr) for your bedroom — the most impactful single lifestyle intervention for PM2.5-exposed asthma patients.

Keep windows closed on high-AQI days; run the air purifier on recirculation mode.

Use anti-allergen encasings on mattresses and pillows to reduce house dust mite exposure.

Control indoor humidity at 40–50% during monsoon using a dehumidifier — this inhibits mould growth.

Eliminate indoor smoking completely. Passive smoke exposure is a Class I asthma trigger with no safe threshold.

Clean air-conditioning filters every 2–4 weeks during heavy use — neglected filters accumulate mould and recirculate allergens.

9. Asthma in Children in Delhi: Dr. Dixit Kumar Thakur’s Specialist Paediatric Care

Childhood asthma is reaching epidemic proportions in Delhi — and Dr. Dixit Kumar Thakur is deeply concerned by what he is seeing at Pulmovista Clinics. Children breathe faster than adults, have narrower airways, and spend more time outdoors during school — making them far more vulnerable to PM2.5-driven asthma than any other group.

Key Facts About Paediatric Asthma in Delhi ✔  Children have a 2–3× higher lung deposition of PM2.5 per kg body weight compared to adults ✔  PM2.5 exposure during the critical lung development window (ages 0–6) causes permanently reduced lung function ✔  Allergic sensitisation to house dust mites, cockroach, and moulds begins in infancy in Delhi homes ✔  School-going children are exposed to unfiltered outdoor air for 6–8 hours daily during term time ✔  Most cases of paediatric asthma in Delhi are allergic — requiring allergy testing and trigger identification

At Pulmovista Clinics, Dr. Dixit Kumar Thakur offers:

Age-appropriate spirometry (reliable from age 5–6) and clinical assessment for younger children

Expert inhaler device selection — spacers with masks for infants and toddlers, spacers alone for school-age, DPIs for adolescents

Written school asthma action plans for nurses and teachers

Full allergen workup and allergen immunotherapy where indicated

Parent education sessions: trigger avoidance, inhaler technique, and exacerbation recognition

10. About Dr. Dixit Kumar Thakur — Senior Pulmonologist, Pulmovista Clinics, Delhi

“My role is not just to prescribe — it is to educate, to empower, and to give patients the tools to achieve the best possible lung health in one of the most challenging respiratory environments in the world.” — Dr. Dixit Kumar Thakur, Best Asthma Specialist in Delhi, Pulmovista Clinics

Dr. Dixit Kumar Thakur is one of Delhi’s most experienced and respected pulmonologists, with 13+ years of dedicated practice at Pulmovista Clinics. His clinical expertise spans the full spectrum of asthma care — from mild intermittent disease to the most complex, treatment-refractory cases requiring biologic therapy. He is recognised as one of the leading practitioners of GINA 2026 precision treatment in Delhi NCR.

Areas of Special Expertise

Severe and difficult-to-treat asthma — phenotyping, precision medicine, and biologic therapy selection

PM2.5 and pollution-related respiratory disease — a growing and critically underserved subspecialty in Delhi

Allergic asthma, allergic rhinitis, and atopic comorbidities

GINA 2026 treatment pathways — MART strategy, FeNO-guided therapy, treatable traits

Paediatric and adult asthma across all age groups

Obstructive sleep apnoea as asthma comorbidity

COPD, bronchiectasis, interstitial lung disease

Why Patients Choose Dr. Dixit Kumar Thakur at Pulmovista for Asthma Treatment in Delhi

Evidence-based GINA 2026 protocols at every consultation

Complete on-site diagnostics: spirometry, FeNO, allergy testing, HRCT, sleep study

Access to all approved biologic therapies with full biomarker workup

Personalised written asthma action plans for every patient

Comorbidity-aware, whole-patient approach

Urgent review availability for deteriorating patients — not just scheduled slots

13+ years of experience managing Delhi-specific asthma triggers and pollution phenotypes

11. When to Seek Emergency Help for Asthma in Delhi

⚠  Call Emergency Services or Go to A&E Immediately If: ›  You are so breathless you cannot complete a full sentence ›  Your lips, fingertips, or face are turning blue (cyanosis) ›  Your rescue inhaler is giving no relief or relief lasting less than 2 hours ›  You can visibly see the muscles in your neck and between your ribs straining with each breath ›  You feel confused, drowsy, or unusually agitated during an attack ›  Your peak flow drops below 50% of your personal best despite rescue medication ›  A child with asthma is breathing very rapidly, is silent (no wheeze = complete obstruction), or appears exhausted

Asthma attacks are potentially fatal. In Delhi, pollution-amplified attacks can escalate faster and to greater severity than in cleaner air environments. Act sooner rather than later. Dr. Dixit Kumar Thakur urges all Pulmovista patients to have a written emergency plan and to use it without hesitation.

FAQs-Dr. Dixit Kumar Thakur Explains Why Delhi’s Air Is Worsening Asthma

  • Dr. Dixit Kumar Thakur at Pulmovista Clinics is one of Delhi's leading pulmonologists specialising in asthma diagnosis, severe asthma management, and biologic therapies. He follows GINA-aligned protocols and offers comprehensive respiratory care for both adults and children.

  • Delhi's PM2.5 levels are frequently 5–7 times above the WHO safe limit. These ultra-fine particles penetrate deep into the lungs, trigger airway inflammation, reduce the effectiveness of standard inhalers, and cause airway hyper-responsiveness — making asthma significantly harder to control in Delhi compared to cleaner cities.
  • Biologic therapies are precision-medicine injections that target specific inflammatory pathways driving severe asthma — such as Omalizumab (anti-IgE), Mepolizumab (anti-IL-5), and Dupilumab (anti-IL-4/IL-13). They are available at Pulmovista Clinics in Delhi, where Dr. Dixit Kumar Thakur conducts full biomarker-based assessments to identify the right biologic for each patient.

  • Winter (November to February) is the most dangerous season for asthma in Delhi. Temperature inversions trap PM2.5 close to ground level, stubble burning from neighbouring states adds a massive pollution surge, cold dry air triggers bronchospasm, and reduced ventilation indoors increases exposure to mould and dust mites — all at the same time.
  • You should see a pulmonologist if you use your rescue inhaler more than twice a week, wake at night with asthma symptoms, have had one or more severe attacks in the past year, or your daily life is limited by breathlessness. At Pulmovista Clinics, Dr. Dixit Kumar Thakur provides specialist-level diagnosis and treatment that goes beyond what a general physician can offer — including spirometry, FeNO testing, allergy workup, and biologic therapy assessment.

Share the Post:

Related Posts